buoyantintelligence
  • 01Overview
  • 02Portfolio
  • 03Company Atlas
    • Buoyant book
    • All listed companies
  • 04Screener & valuation
  • 05House view
  • 06Markets
  • 07India top-down
  • 08Investors
  • 09Library & data
Release
August 2026 · rev 1
Opportunities PMS · Published
As at 31 Aug 2026 · IST₹ · ₹ cr · BSE 500 TRI
Present
Internal working platform. Published figures are extracted from the August 2026 source package and reviewed; reference prices and fundamentals are unlicensed working data, not for redistribution. Past performance is not indicative of future returns.
All listed companies/Alkem Laboratories Limited
03 /Listed universe · Healthcare · Pharmaceuticals

Alkem Laboratories Limited.

Value itCompareScreener.in ↗Tijori ↗NSE ↗BSE ↗
Snapshot

Healthcare · Pharmaceuticals

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers biosimilars, active pharmaceutical ingredients, branded and trade generics, complex generics, and consumer wellness products in therapeutic areas comprising anti – infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology, central nervous system, anti-diabetic, iron deficiency, pain management, and urology, as well as vitamins, minerals, and nutrients. It also provides cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. Alkem Laboratories Limited was incorporated in 1973 and is based in Mumbai, India.

Market cap
₹63,813 cr
P/E (TTM)
29.5
P/B (latest)
4.6
ROE (TTM)
16.7%
ROCE (TTM)
22.5%
Sales CAGR 3y
8.3%
PAT CAGR 3y
32.7%
Debt / equity
0.12x
Promoter
49.7%
Dividend yield
0.99%
Size
Mid
Codes
ALKEM · 539523
Price

₹5,250 · 29 Sept 2026

1M
−2.0%
3M
−3.1%
6M
−1.8%
YTD
−3.9%
1Y
−2.9%
3Y
+49.6%
5Y
—
vs 52w high
−10.9%

52-week ₹5,087.5 – ₹5,890 · ADTV ₹73.2 cr · price-only.

Trend

Sales and net profit by fiscal year, ₹ crore

Not in the Buoyant book: no house thesis or target is carried. Exchange masters, Tijori and the reference price feed as stated on each tab. All listed companies · NSE EQ